These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 35181378

  • 1. Primary cardiac undifferentiated pleomorphic sarcoma is associated with TP53 mutation during lack of MDM2 amplification, and targeted sequencing analysis reveals potentially actionable targets.
    Cui Y, Han L, Shang J, Fang W, Zhao M, Chen D, Liu H.
    Hum Pathol; 2022 May; 123():113-122. PubMed ID: 35181378
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. MDM2 dual-color in situ hybridization (DISH) aids the diagnosis of intimal sarcomas.
    Jimbo N, Komatsu M, Itoh T, Hirose T.
    Cardiovasc Pathol; 2019 May; 43():107142. PubMed ID: 31442826
    [Abstract] [Full Text] [Related]

  • 5. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
    Hasegawa N, Hayashi T, Niizuma H, Kikuta K, Imanishi J, Endo M, Ikeuchi H, Sasa K, Sano K, Hirabayashi K, Takagi T, Ishijima M, Kato S, Kohsaka S, Saito T, Suehara Y.
    Clin Orthop Relat Res; 2024 Mar 01; 482(3):549-563. PubMed ID: 38014853
    [Abstract] [Full Text] [Related]

  • 6. Intimal Sarcoma with MDM2/CDK4 Amplification and p16 Overexpression: A Review of Histological Features in Primary Tumor and Xenograft, with Immunophenotype and Molecular Profiling.
    Giner F, Machado I, Rubio-Martínez LA, López-Guerrero JA, Claramunt-Alonso R, Navarro S, Ferrández A, Mayordomo-Aranda E, Llombart-Bosch A.
    Int J Mol Sci; 2023 Apr 19; 24(8):. PubMed ID: 37108696
    [Abstract] [Full Text] [Related]

  • 7. Dysplastic Lipoma: A Distinctive Atypical Lipomatous Neoplasm With Anisocytosis, Focal Nuclear Atypia, p53 Overexpression, and a Lack of MDM2 Gene Amplification by FISH; A Report of 66 Cases Demonstrating Occasional Multifocality and a Rare Association With Retinoblastoma.
    Michal M, Agaimy A, Contreras AL, Svajdler M, Kazakov DV, Steiner P, Grossmann P, Martinek P, Hadravsky L, Michalova K, Svajdler P, Szep Z, Michal M, Fetsch JF.
    Am J Surg Pathol; 2018 Nov 19; 42(11):1530-1540. PubMed ID: 30001242
    [Abstract] [Full Text] [Related]

  • 8. Mutations of TP53, amplification of EGFR, MDM2 and CDK4, and deletions of CDKN2A in malignant astrocytomas.
    Biernat W, Debiec-Rychter M, Liberski PP.
    Pol J Pathol; 1998 Nov 19; 49(4):267-71. PubMed ID: 10323080
    [Abstract] [Full Text] [Related]

  • 9. Intimal sarcoma is the most frequent primary cardiac sarcoma: clinicopathologic and molecular retrospective analysis of 100 primary cardiac sarcomas.
    Neuville A, Collin F, Bruneval P, Parrens M, Thivolet F, Gomez-Brouchet A, Terrier P, de Montpreville VT, Le Gall F, Hostein I, Lagarde P, Chibon F, Coindre JM.
    Am J Surg Pathol; 2014 Apr 19; 38(4):461-9. PubMed ID: 24625414
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Gene abnormalities in multiple myeloma; the relevance of TP53, MDM2, and CDKN2A.
    Elnenaei MO, Gruszka-Westwood AM, A'Hernt R, Matutes E, Sirohi B, Powles R, Catovsky D.
    Haematologica; 2003 May 19; 88(5):529-37. PubMed ID: 12745272
    [Abstract] [Full Text] [Related]

  • 13. MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status.
    Flørenes VA, Maelandsmo GM, Forus A, Andreassen A, Myklebost O, Fodstad O.
    J Natl Cancer Inst; 1994 Sep 07; 86(17):1297-302. PubMed ID: 8064888
    [Abstract] [Full Text] [Related]

  • 14. Are peripheral purely undifferentiated pleomorphic sarcomas with MDM2 amplification dedifferentiated liposarcomas?
    Le Guellec S, Chibon F, Ouali M, Perot G, Decouvelaere AV, Robin YM, Larousserie F, Terrier P, Coindre JM, Neuville A.
    Am J Surg Pathol; 2014 Mar 07; 38(3):293-304. PubMed ID: 24525499
    [Abstract] [Full Text] [Related]

  • 15. TP53 in bone and soft tissue sarcomas.
    Thoenen E, Curl A, Iwakuma T.
    Pharmacol Ther; 2019 Oct 07; 202():149-164. PubMed ID: 31276706
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Genomic profiling of BCOR-rearranged uterine sarcomas reveals novel gene fusion partners, frequent CDK4 amplification and CDKN2A loss.
    Lin DI, Hemmerich A, Edgerly C, Duncan D, Severson EA, Huang RSP, Ramkissoon SH, Connor YD, Shea M, Hecht JL, Ali SM, Vergilio JA, Ross JS, Elvin JA.
    Gynecol Oncol; 2020 May 07; 157(2):357-366. PubMed ID: 32156473
    [Abstract] [Full Text] [Related]

  • 20. Atypical fibroxanthoma and pleomorphic dermal sarcoma harbor frequent NOTCH1/2 and FAT1 mutations and similar DNA copy number alteration profiles.
    Griewank KG, Wiesner T, Murali R, Pischler C, Müller H, Koelsche C, Möller I, Franklin C, Cosgarea I, Sucker A, Schadendorf D, Schaller J, Horn S, Brenn T, Mentzel T.
    Mod Pathol; 2018 Mar 07; 31(3):418-428. PubMed ID: 29099504
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.